CardiomyopathyNCT02471417
Acute Dietary Nitrate in Dilated Cardiomyopathy
A study testing Dietary nitrate in people with Cardiomyopathy, run by Royal College of Surgeons, Ireland.
Trial summary
Acute consumption of dietary nitrate (as beetroot juice) has been shown to improve exercise capacity in athletes, healthy adults and subjects with both peripheral vascular disease or COPD. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Cardiomyopathy
- What is being tested?
- Dietary nitrate
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 12 participants
- Where
- No sites listed yet
- Study dates
- Jan 2015to May 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Clinically stable,
- Confirmed non-ischemic, dilated cardiomyopathy
Who cannot join
- Active musculo-skeletal conditions
- Ischemic heart disease
- Pulmonary hypertension
- COPD
- Taking vasodilators
- Diabetes mellitus
About this study
Official title: Dietary Nitrate Supplementation in Dilated Cardiomyopathy: An Acute, Double-blind, Randomized, Placebo-controlled, Crossover Trial.
Acute consumption of dietary nitrate (as beetroot juice) has been shown to improve exercise capacity in athletes, healthy adults and subjects with both peripheral vascular disease or COPD. Many patients with dilated cardiomyopathy have reduced exercise capacity, The investigators hypothesized that acute nitrate consumption might increase incremental shuttle walk test (ISWT) distance in dilated cardiomyopathy subjects compared to a placebo beetroot juice.
Read the detailed description
Acute consumption of dietary nitrate (as beetroot juice) has been shown to improve exercise capacity in athletes, healthy adults and subjects with both peripheral vascular disease or COPD. Many patients with dilated cardiomyopathy have reduced exercise capacity, The investigators hypothesized that acute nitrate consumption might increase incremental shuttle walk test (ISWT) distance in dilated cardiomyopathy subjects compared to a placebo beetroot juice. This study is a randomized, double-blind placebo-controlled, crossover trial. Resting blood pressure, phlebotomy and ISWT will be performed. Following completion, each subject is randomized to consume beetroot juice or placebo. 3 hours later, the same assessments are repeated by the same people. After a 7d washout, the entire protocol is repeated with the crossover beverage.
- Conditions
- Cardiomyopathy
- Being tested
- Dietary nitrate, Placebo
- Medical subject headings
- Cardiomyopathies
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dietary nitrateDietary supplement
Also called Beetroot juice
140ml of nitrate rich beetroot juice provides 12.9mmol nitrate and will be on a single occasion by the study subjects.
PlaceboDietary supplement
Also called Nitrate depleted beetroot juice
140ml of nitrate depleted beetroot juice provides 0.5mmol nitrate and will be on a single occasion by the study subjects.
| Study group | Role | What they receive |
|---|---|---|
| Nitrate rich beetroot juice | Experimental | Concentrated, beetroot juice is a rich source of dietary nitrate. Receives: Dietary Supplement: Dietary nitrate |
| Nitrate depleted placebo beetroot juice | Placebo comparator | Placebo beetroot juice is identical to active beetroot juice in every way except nitrate content. Receives: Dietary Supplement: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change between incremental shuttle walk test distance pre and post juice
Measured: Day 1 and day 8
Secondary outcomes (5)
Clinic blood pressure
Measured: Day 1 and day 8
Plasma nitrate
Measured: Day 1 and day 8
Dyspnoea using self report, validated Borg scale
Measured: Day 1 and day 8
Oxygen saturation using pulse oximetry
Measured: Day 1 and day 8
Plasma nitrite
Measured: Day 1 and day 8
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jun 2015 (estimated)
- Study startJan 2015
- Primary completionMay 2015
- Study completionMay 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CardiomyopathyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 12 participants (actual)
Sponsor and investigators
- Lead sponsor
- Royal College of Surgeons, Ireland
- Sponsor type
- University, hospital or other
- Collaborators
- University College Dublin, Connolly Hospital Blanchardstown
- Responsible party
- Sponsor
- Investigators
- Jim O 'Neill, MD, Principal investigator, Connolly Hospital Blanchardstown
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02471417
- Sponsor's protocol ID
- Acute NO3- in DCM
- Status last verified
- Jun 2015
- First submitted
- 7 Jan 2015
- Last updated
- 15 Jun 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Jun 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Dietary Nitrate Supplementation in Dilated Cardiomyopathy: An Acute, Double-blind, Randomized, Placebo-controlled, Crossover Trial.
- ClinicalTrials.gov ID
- NCT02471417
- Acronym / sponsor ID
- Acute NO3- in DCM
- Conditions
- Cardiomyopathy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 12 participants (actual)
- Lead sponsor
- Royal College of Surgeons, IrelandUniversity, hospital or other
- Collaborators
- University College Dublin, Connolly Hospital Blanchardstown
- Study start
- Jan 2015
- Primary completion
- May 2015 (actual)
- Study completion
- May 2015 (actual)
- First posted
- 15 Jun 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Acute consumption of dietary nitrate (as beetroot juice) has been shown to improve exercise capacity in athletes, healthy adults and subjects with both peripheral vascular disease or COPD. Many patients with dilated cardiomyopathy have reduced exercise capacity, The investigators hypothesized that acute nitrate consumption might increase incremental shuttle walk test (ISWT) distance in dilated cardiomyopathy subjects compared to a placebo beetroot juice.
Detailed description
Acute consumption of dietary nitrate (as beetroot juice) has been shown to improve exercise capacity in athletes, healthy adults and subjects with both peripheral vascular disease or COPD. Many patients with dilated cardiomyopathy have reduced exercise capacity, The investigators hypothesized that acute nitrate consumption might increase incremental shuttle walk test (ISWT) distance in dilated cardiomyopathy subjects compared to a placebo beetroot juice. This study is a randomized, double-blind placebo-controlled, crossover trial. Resting blood pressure, phlebotomy and ISWT will be performed. Following completion, each subject is randomized to consume beetroot juice or placebo. 3 hours later, the same assessments are repeated by the same people. After a 7d washout, the entire protocol is repeated with the crossover beverage.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Nitrate rich beetroot juice | Experimental | Dietary Supplement: Dietary nitrateConcentrated, beetroot juice is a rich source of dietary nitrate. |
| Nitrate depleted placebo beetroot juice | Placebo comparator | Dietary Supplement: PlaceboPlacebo beetroot juice is identical to active beetroot juice in every way except nitrate content. |
Who may qualify
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- Clinically stable,
- Confirmed non-ischemic, dilated cardiomyopathy
Key exclusion criteria (6 listed)
- Active musculo-skeletal conditions
- Ischemic heart disease
- Pulmonary hypertension
- COPD
- Taking vasodilators
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Dietary nitrateAlso: Beetroot juice140ml of nitrate rich beetroot juice provides 12.9mmol nitrate and will be on a single occasion by the study subjects. | Dietary supplement | Nitrate rich beetroot juice |
| PlaceboAlso: Nitrate depleted beetroot juice140ml of nitrate depleted beetroot juice provides 0.5mmol nitrate and will be on a single occasion by the study subjects. | Dietary supplement | Nitrate depleted placebo beetroot juice |
Primary outcome
Change between incremental shuttle walk test distance pre and post juice
Time frame: Day 1 and day 8
5 secondary outcomes
Clinic blood pressure
Time frame: Day 1 and day 8
Plasma nitrate
Time frame: Day 1 and day 8
Dyspnoea using self report, validated Borg scale
Time frame: Day 1 and day 8
Oxygen saturation using pulse oximetry
Time frame: Day 1 and day 8
Plasma nitrite
Time frame: Day 1 and day 8
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jun 2015.
Related trials for Cardiomyopathy
Not yet recruiting
Human Experimental Models of Pain (HEMP)
Acute Pain
Not yet recruiting
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices
Hypertrophic Cardiomyopathy, Left Ventricular Outflow Obstruction
RecruitingObservational study
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Metabolic Disease, Obesity
RecruitingObservational study
A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease
Coronary Artery Disease, Myocarditis
RecruitingObservational study
Swiss Cardiac Amyloidosis REgistry (Swiss-CARE)
Amyloid Cardiomyopathy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jim O 'Neill, MD principal investigator
Connolly Hospital Blanchardstown
Questions about this trial
What is this clinical trial studying?
A study testing Dietary nitrate in people with Cardiomyopathy, run by Royal College of Surgeons, Ireland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change between incremental shuttle walk test distance pre and post juice (time frame: Day 1 and day 8). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2015; AzTrials last refreshed its copy on 6 Nov 2026.